NKGen Biotech Stock (NASDAQ:NKGN)

Ownership Financials Chart

Previous Close

$0.30

52W Range

$0.20 - $4.06

50D Avg

$0.39

200D Avg

$1.08

Market Cap

$10.30M

Avg Vol (3M)

$1.22M

Beta

0.52

Div Yield

-

NKGN Company Profile

Graf Acquisition Corp. IV does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. Graf Acquisition Corp. IV was incorporated in 2021 and is based in The Woodlands, Texas.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

63

IPO Date

Oct 02, 2023

Website

NKGN Performance

NKGN Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	-	$77.00K	$426.00K
Operating Income	$-29.75M	$-24.35M	$-21.86M
Net Income	$-82.95M	$-26.75M	$-23.27M
EBITDA	$-28.54M	$-22.79M	$-20.70M
Basic EPS	$-5.38	$-0.82	$-0.71
Diluted EPS	$-5.38	$-0.82	$-0.71

Fiscal year ends in Dec 23 | Currency in USD